AKRO
🚫 does not pay dividends

Company News

Halper Sadeh LLC Encourages SEE, AXTA, SEMR, AKRO Shareholders to Contact the Firm to Discuss Their Rights
GlobeNewswire Inc. • Halper Sadeh Llc • November 20, 2025

Law firm investigating potential securities law violations and fiduciary duty breaches for several companies involved in recent merger and acquisition transactions.

SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-HOUS, CRTAF, BRY, and AKRO
Benzinga • Juan Monteverde • November 18, 2025

Law firm Monteverde & Associates is investigating potential merger-related class action lawsuits for several companies, including Anywhere Real Estate, Cartica Acquisition, Berry Corporation, and Akero Therapeutics.

Halper Sadeh LLC Encourages JAMF, CADE, AKRO, GES Shareholders to Contact the Firm to Discuss Their Rights
GlobeNewswire Inc. • Halper Sadeh Llc • November 7, 2025

Law firm Halper Sadeh LLC is investigating potential securities law violations and breaches of fiduciary duties for several companies undergoing mergers and acquisitions.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Qorvo, Inc. (Nasdaq – QRVO), First Foundation Inc. (NYSE – FFWM), Akero Therapeutics, Inc. (Nasdaq - AKRO), CoreCard Corporation (NYSE - CCRD)
GlobeNewswire Inc. • Brodsky & Smith • November 6, 2025

Law firm Brodsky & Smith is investigating potential breaches of fiduciary duties by boards of several companies during merger and acquisition processes, focusing on whether shareholders are receiving fair value.

Novo Nordisk's sales increased by 12% in Danish kroner and by 15% at CER in the first nine months of 2025; R&D pipeline progress continues
GlobeNewswire Inc. • Novo Nordisk • November 5, 2025

Novo Nordisk reported 12% sales growth in Q3 2025, with strong performance in Obesity and Diabetes care. The company is undergoing a transformation, incurring restructuring costs, and adjusting growth expectations for GLP-1 treatments.

Related Companies